News
Cardurion heads crop of sizeable bio financings

Cardurion heads crop of sizeable bio financings

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.

R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.

R&D
2nd Covalent Drug Discovery & Development Summit banner image
Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.

R&D
2nd Covalent Drug Discovery & Development Summit banner image
Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

Debates & Insights

News

News
Cardurion heads crop of sizeable bio financings

Cardurion heads crop of sizeable bio financings

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.

Press Releases

Newsletters and Deep Dive
digital magazine

Views & Analysis

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

Deep Dive

R&D
Heard on the pipeline hexagon graphical banner

Heard on the pipeline: AI in R&D

As has become tradition in the pharma and biotech world, 2024 kicked off with a bang as experts from around the globe gathered in San Francisco for the 42nd annual JP Morgan Health Conferen

Webinars

Podcasts

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

Video

R&D
Veeva R&D and Quality 2024 - Chris Moore

Veeva R&D and Quality 2024: Chris Moore

During the Veeva R&D and Quality Summit held in Madrid last month, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to discuss the event and i

R&D
Dr Suzanne Trudel at ASCO 2024

ASCO 2024 - Suzanne Trudel

Sometimes getting a new drug to market is a relatively straight line, but sometimes it’s a winding road.

White Papers

R&D
Envisioning a World Without Disease - whitepaper

Envisioning a World Without Disease

In June, pharmaphorum came together with the Connected World Without Disease Accelerator for the inaugural World Without Disease Summit, a two-day event that brought together stakeholders f

Event

R&D
FT US Pharma and Biotech Summit

FT US Pharma and Biotech Summit: Live coverage

This week, pharmaphorum heads to the Big Apple for the FT US Pharma and Biotech Summit, a one-day event where executives from some of the world’s top pharma companies will come together to

R&D
FT LiveUS Pharma and Biotech Summit 2023

FT Live US Pharma and Biotech Summit 2023

At the FT’s US Pharma and Biotech Summit in New York City, 16th and 17th May, leaders from across the pharma landscape will gather to discuss some of the hottest topics in US pharma, includ

Partner Content

R&D
2nd Covalent Drug Discovery & Development Summit banner image
Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.

R&D
7th TPD & Induced Proximity Summit banner image
Partner Content

7th TPD & Induced Proximity Summit

Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address